| Liquid Breathing |
Article Index for Liquid |
Shopping Breathing |
Website Links For Liquid |
Information AboutLiquid Breathing |
| CATEGORIES ABOUT LIQUID BREATHING | |
| diving | |
| respiration | |
| university at buffalo | |
|
THE EARLY EXPERIMENTS In the mid-1960s Dr. J. Kylstra , a Physiologist at the University At Buffalo , realized that salt solutions could be saturated with Oxygen at high pressures. In a US Navy Recompression Chamber , Kylstra experimented to see if mice could move the saline solution in and out of their lungs, while extracting enough oxygen from the fluid to survive. The mice and rats could breathe the liquid (he could keep the animals alive for up to 18 hours), but Carbon Dioxide was not removed fast enough from the system, and quickly built up to Near-toxic Levels . This had to be fixed before liquid breathing could be used in humans. In 1966 Dr. Leland Clark and Dr. Golan experimented on liquid breathing in mice. Oxygen and carbon dioxide are very soluble in Fluorocarbon liquids such as Freon . Leland Clark realized that, if the Alveoli of the Lung s can draw oxygen out of the liquid and unload carbon dioxide into the liquid, these fluorocarbons should support respiration of animals. Testing first on anesthetized Mice , he temporarily paralyzed each animal and put a tube down its trachea, inflating a cuff inside the airway to provide a seal and ensure that no air entered the lungs, and no solution leaked out''Science'' (24 June 1966). After bubbling oxygen through the fluorocarbon, the oxygenated fluid was pumped into the animals' lungs, and recirculated at about 6 cycles of inhalation and exhalation per minute. Most of the animals who were kept in the fluid for up to an hour survived for several weeks after their removal, before eventually succumbing to pulmonary damage. Autopsies uniformly revealed that the lungs appeared congested when collapsed but normal when inflated. As in Kylstra's studies, Clark had problems due to the size of the animals' airways. The tiny size limited the amount of fluid that could get into the lungs. For that and other reasons, carbon dioxide tended to build up in the system and could not be removed fast enough. Dr. Clark discovered that the length of time the mice could survive in the fluid was directly related to the fluorocarbon's temperature: the colder the fluid, the lower the respiration rate, which prevented Carbon Dioxide Buildup . The only way was to induce hypothermia in the animals. This technique seemed to give him the most success, as one animal survived over 20 hours breathing fluid at 18 ºC. All animals in the earliest studies suffered lung damage, but whether that was due to toxic impurities in the fluorocarbon, chemical interaction of the fluorocarbon with the lung, or some unknown effect, was undetermined. This mystery of the lung damage, and the problem of carbon dioxide elimination, and the body tissues tending to retain the fluorocarbon, would have to be solved before the process could be attempted on human subjects. Also, Perfluorocarbon is Denser and more Viscous than air. This increases Resistance and thus the effort needed to breathe. LATER DEVELOPMENTS During later years, the techniques of fluid breathing were constantly refined and improved. The survival rate of all the tested animals in recent years has been very high, thanks mainly to improvements in carbon dioxide elimination. Current fluids used can dissolve over 65 Ml of Oxygen and 228 ml of Carbon Dioxide per 100 ml Perfluorocarbon . By the early 1990s this procedure developed: #The animal was anesthetized with intravenous Sodium Thiopental . #The animal was put on its back. A tube was placed down its airway, ready for the liquid breathing medium. #A blood sample was taken. The temperature of the fluid was adjusted correspondingly. It was no longer necessary to make the animals Hypothermic . #The Perfluorocarbon was instilled into the animal's lungs through the tube. #A floor-mounted 3-litre reservoir was filled with the perfluorocarbon. The liquid was driven by a pump through a series of machines which warmed and oxygenated the liquid and took the carbon dioxide out of it. The liquid flowed through a tube into a 3-way pneumatic valve which directed flow to the animal. A computer controlled the inspiration (18 ml of fluid per second), pumping the liquid into the animal's lungs, then back out again to the reservoir, at a rate of about 6 complete respirations per minute. #At the end of the test, the animal was tilted for about 15 seconds and the perfluorocarbon was allowed to drain from the lungs. This can be seen in the film '' The Abyss '' where Ensign Monk drained the fluid out of the rat's lungs: in the filming, the rat genuinely breathed liquid. These tests of the early 90s were successful: dogs could be kept alive in the perfluorcarbon medium for about 2 hours; after removal the dogs were usually slightly hypoxic, but returned to normal after a few days. When the animals were Autopsied , the typical findings were mild Oedema and some Hemorrhaging , clearly an improvement over the lung damage of earlier tests. USE IN DIVING Breathing liquid instead of air seems odd, but if the technique could be perfected it would revolutionize diving. In diving, the pressure inside the lungs must equal the pressure outside the body, otherwise the lungs collapse. Thus, if the diver is ''f'' feet or ''m'' meters deep, and the air pressure at the water surface is ''p'' and other Diving Disorders , like Nitrogen Narcosis and Decompression Sickness . One solution is a Rigid Articulated Diving Suit , but these are bulky and clumsy. A more moderate option is to breathe Heliox or Trimix , in which some or all of the Nitrogen is replaced by Helium . With liquid in the lungs, the pressure in our body could accommodate changes in the pressure of the surrounding water without the huge gas partial pressure changes required when the lungs are filled with gas. The elimination of gasses at high partial pressures would eliminate the need for Decompression and its above inherent problems. If the technique could be perfected, it would be extremely useful for submarine escape and undersea oxygen support facilities, and for underwater work, as portrayed in the 1989 science-fiction film '' The Abyss ''. Unfortunately, there are problems with execution of the idea. All uses of liquid breathing for diving must involve total liquid ventilation. Any bubbles in the system at all would need to be maintained by the kinds of high partial gas pressures that it is the whole point of the system to avoid. Bubbles would lead to bends. Total liquid ventilation, however, has difficulty moving enough fluid to carry away CO2, because no matter how great the total pressure is, the amount of partial CO2 gas pressure available to disolve CO2 into the breathing liquid can never be much more than the pressure of 40 mm of mercury (Torr) at which CO2 exists in the blood. At these pressures, most fluorocarbon liquids require about 70 mL/kg minute-venilation volumes of liquid (about 5 L/min for a 70 kg adult) to remove enough CO2 for normal resting metabolism. This is a great deal of fluid to move when it represents dense liquid (about 1.8 times the density of water), and even moderate work which doubles CO2 production, would double this figure. It seems unlikely that a person would move 10 liters/min of fluorocarbon liquid without assistance from a mechanical ventilator, so "free breathing" of liquids by working human aquanauts as seen in the film '' The Abyss ,'' will probably be a long time coming. MEDICAL USES The immediate use of liquid breathing is likely to be in treating premature babies, and adults with severe lung damage from causes such as Fire s. Liquid breathing began to be used by the medical community after the development by Alliance Pharmaceuticals of the fluorochemical Perfluorooctyl Bromide , or Perflubron for short. Useful as a blood substitute and for liquid ventilation, perflubron (under Alliance Pharmaceutical's brand name LiquiVent ) is instilled directly into the lungs of patients with acute respiratory failure (caused by infection, severe burns, inhalation of toxic substances, and premature birth), whose air sacs have collapsed. Once inside the lungs, perflubron enables collapsed alveoli (air sacs) to open and permits a more efficient transport of oxygen and carbon dioxide. Current tests are focusing on premature babies, but trials with adults are ongoing. All blood that flows out from the heart to the rest of the body first must go through the lungs, where it picks up oxygen and gets rid of carbon dioxide. If the lungs do not function properly, as is common in premature infants with respiratory distress syndrome, the lungs become stiff and collapse, and the infants must be put on ventilators. A study, led by Dr. Corrinne Leach of the University At Buffalo , tested 13 infants on ventilators who were born prematurely with respiratory distress syndrome. The infants were at risk of dying because they could not produce a natural Surfactant that stops the lungs from collapsing from Surface Tension . They were at risk of severe and permanent lung damage from the force of the ventilators that were inflating their lungs. Their lungs were filled with perflubron which would let the air sacs of the lungs open and permit breathing. The perflubron let the lungs inflate with less pressure and let Oxygen pass through the lungs and into the blood stream and Carbon Dioxide out more efficiently and with less stress. This was successful. The 13 premature infants received partial liquid ventilation for 24 to 76 hours; they were weaned back to gas ventilation without difficulties or adverse side effects, and 11 of the 13 showed significant improvement in lung functioning. Six of the infants eventually died, but of causes apparently unrelated to the liquid ventilation. Clinical trials with premature infants, children and adults were conducted. Since the safety of the procedure and the effectiveness of the gas exchange have improved so much, the US Food And Drug Administration (FDA) gave the product "fast track" status (meaning an accelerated review of the product, designed to get it to the public as quickly as is safely possible) due to its life-saving potential. Unfortunately, results of the clinical trials were disappointing and Alliance is no longer pursuing partial liquid ventilation application. Mode of application Despite recent advances in liquid ventilation, a standard mode of application of perfluorocarbon (PFC) has not been established yet. TLV Although total liquid ventilation (TLV) with completely liquid filled lungs is beneficial, the necessity for a liquid filled tube system that contains pumps, heater and membrane oxygenator to deliver and remove tidal volume aliquots of conditioned perfluorocarbon to the lungs is of great disadvantage. PLV In contrast, partial liquid ventilation (PLV) can be applied using standard ventilators connected with gas filled standard respirator systems, delivering tidal volumes of oxygen-air mixture to perfluorocarbon filled lungs. The influence of PLV on oxygenation, carbon dioxide removal and lung mechanics has been investigated in several animal studies using different models of lung injury. Clinical applications of PLV have been reported in patients with acute respiratory distress syndrome ( ARDS ), meconium aspiration syndrome, congenital diaphragmatic hernia and respiratory distress syndrome (RDS) of neonates. PLV requires extreme respiratory care, because the ventilatory setting is determined by the perfluorocarbon filled lung. Profound expertise is mandatory to perform and maintain filling of the lung with perfluorocarbon to functional residual capacity (FRC). Disruption of PLV immediately deteriorates gas exchange. Incomplete filling of the lung has been shown to be less effective than filling the lung to functional residual capacity volume. Severe adverse events affecting gas exchange and pulmonary circulation limit the use of PLV. New application modes for PFC have been developed"A significant positive step was the use of PFC-associated gas exchange, now termed partial liquid ventilation (PLV)." 1. PFC vapor Vaporization of Perfluorohexane with two anesthetic vaporizers calibrated for perfluorohexane has been shown to improve gas exchange in oleic acid induced lung injury in sheep "Vaporization is a new application technique for perfluorocarbon that significantly improved oxygenation and pulmonary function in oleic acid-induced lung injury." 2. Predominantly PFCs with high vapor pressure are suitable for vaporization. Aerosol-PFC With aerosolized Perfluorooctane , significant improvement of oxygenation and pulmonary mechanics was shown in adult sheep with Oleic Acid -induced lung injury. In Surfactant -depleted Piglet s, persistent improvement of gas exchange and lung mechanics was demonstrated with Aerosol-PFC "Aerosolized perfluorocarbon improved pulmonary gas exchange and lung mechanics as effectively as PLV did in surfactant-depleted piglets, and the improvement was sustained longer." 3. The aerosol device is of decisive importance for the efficacy of PFC aerosolization, as aerosolization of PF5080 (a less purified FC77 ) has been shown to be ineffective using a different aerosol device in surfactant-depleted rabbits (Kelly). Partial liquid ventilation and Aerosol-PFC reduced pulmonary inflammatory response "In a surfactant-depleted piglet model, aerosol therapy with perfluorocarbon but not LV-PLV reduces the initial pulmonary inflammatory reaction at least as potently as PLV at FRC volume." 4. SPACE TRAVEL Around 1970 , liquid breathing found its way into Fiction , in alien Spacesuit s in the Gerry Anderson UFO Series , which enabled a Spaceman to withstand extreme acceleration forces. Forces applied to fluids (such as gravitational forces on Earth) are distributed as omnidirectional pressures. This fact is fundamental to all Hydraulics . In the ocean, this distribution of force allows organisms such as Whales to grow to sizes that would be unsupportable on dry land. Because liquids are incompressible, they do not change density under high acceleration such as performed in aerial maneuvers or space travel. A man immersed in such a liquid would have inertial forces distributed around his body, rather than applied at a single point such as a seat or harness straps. The effect of high acceleration is caused by different parts of the accelerating volume having different densities and thus different .) However, such application is probably physically and anatomically not possible. The main problem with acceleration forces is that they force the heart to pump blood at much higher pressures. Liquid breathing would not change that. Moreover, filling lungs with liquid, especially as heavy as perflurocarbon, will dramatically increase their weight. At extreme G forces, experienced by pilots and astronauts, the lungs are likely to rupture if filled with liquid. ACKNOWLEDGEMENT Taken, with permission, from: Fluid Breathing , and afterwards edited. REFERENCES SEE ALSO EXTERNAL LINKS |
|
|